Shawn Sarkaria
0000-0003-2248-4934
Publication & Citation Trends
Publications
25 total
Systematic dissection of coordinated stromal remodeling identifies Sox10 glial cells as a therapeutic target in myelofibrosis PDF
Cited by 15
OpenAlex
Trial in Progress: A Phase 2 Study of Linvoseltamab for the Treatment of High-Risk Smoldering Multiple Myeloma (LINKER-SMM1)
Cited by 4
OpenAlex
Trial in Progress: REGN5458, a BCMAxCD3 Bispecific Antibody, in a Phase Ib Multi-Cohort Study of Combination Regimens for Patients with Relapsed/Refractory Multiple Myeloma
Cited by 7
OpenAlex
Bone Marrow Micro‐Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies PDF
Cited by 23
OpenAlex
Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro PDF
Cited by 39
OpenAlex
Genomic impact of transient low-dose decitabine treatment on primary AML cells
Cited by 204
OpenAlex
Research Topics
Multiple Myeloma Research and Treatments
(9)
Histone Deacetylase Inhibitors Research
(7)
Acute Myeloid Leukemia Research
(6)
Cancer Treatment and Pharmacology
(6)
HER2/EGFR in Cancer Research
(5)
Affiliations
University of California, Los Angeles
Regeneron (United States)
Columbia University Irving Medical Center
Progenics Pharmaceuticals (United States)
Columbia University